TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors
de Oliveira ÉA., Chauhan J., da Silva JR., da Costa Carvalho LA., Dias D., de Carvalho DG., Watanabe LRM., Rebecca VW., Mills G., Lu Y., da Silva ASF., Consolaro MEL., Herlyn M., Possik PA., Goding CR., Maria-Engler SS.